Stereotaxis, Inc. was officially founded in 1990 by a pioneering group of medical researchers, engineers, and physicians who sought to revolutionize minimally invasive surgery by harnessing advanced magnetic fields. Over the subsequent decade and a half, the enterprise focused heavily on intensive research, engineering design, and clinical development before completing its initial public offering in 2004. Since its inception, the company has remained at the forefront of medical technology innovation, developing proprietary robotic magnetic navigation platforms and specialized catheter systems designed to improve procedural accuracy and patient outcomes during complex electrophysiology and cardiovascular interventions.